9/19/2007Zhejiang NHU Raises VE Price Again

9/19/2007SFDA Publishes Draft of "Supplemental Rules for Registration of T...

9/18/2007RDPAC Kicks Off New Code and MR Certification Program

9/17/2007Upcoming Event - Optimising Pharma Product Lifecycle: Revitalising the...

9/16/2007SFDA Recalls Tainted Leukemia Drugs

9/14/2007Sanofi-Aventis Announced Major Research Deal with CAMS

9/13/2007SAFC to Build First Chinese Facility in Wuxi

9/12/2007SFDA to Seek Public Comments on Drug Product Recall System

9/12/2007Jointown to Acquire Shandong Yaoshan Pharma

9/12/2007Debate over Hospital Financing Model Heat Up

9/11/2007SFDA Announces New Requirements for Import and Export Drug Products

9/11/2007SFDA Issues the No.118 Announcement of Drug Administrative Protection ...

9/11/2007China Face Albumin Shortage but Retain Ban on Imports of Blood Product...

9/11/2007Sinovac Begins Phase II Trials of Its H5N1 Vaccine

9/7/2007Healthcare Reform Plan Draft to be Ready for Public Comments by Mid-Se...

9/7/2007SASAC May Leave SinoPharm Intact Following Top Personnel Changes

9/7/2007Chinese Exports of Finished Western Medicines Grew Sharply in the Firs...

9/7/2007Yangzhou Pharma Inspected by German Authorities

9/7/2007WHO Prequalifies Guilin Pharma's Malaria Drugs

9/6/2007Health Minister Chen Zhu Talks to Press about Healthcare Reform

9/6/2007Production and Sales of Methotrexate and Cytarabin Suspended

9/5/2007Xian-Janssen Launches Remicade

9/5/2007New Report Suggest Future Sharp Rise in Chinese Asthma Patient Populat...

9/5/2007Omnicom Acquires Consultech

9/5/2007Pharma Companies Face Challenge under New Environmental Regulations

9/5/2007AstraZeneca Establishes Clinical Pharmacology Unit in China

9/1/2007Second Hand Smoke May Cause 1.9 Million COPD Extra Deaths In China

9/1/2007Shares of Wuxi PharmaTech Climbed 91%

9/1/2007Sanchine Pharma to Acquire Harbin No.4 Pharma

9/1/2007Biopharmaceutical IP Protection in China (External)

Page:373/374 Total number of articles:11205: [First][<<] [370] [371] [372] [373] [374] [>>] [End]